CJC-1295, Ipamorelin (5/5mg)

CJC-1295 + Ipamorelin Blend

The CJC-1295 + Ipamorelin blend combines two well-known peptides that have been widely studied in growth hormone–related signalling pathways. In research settings, this pairing is often explored due to their complementary interaction with growth hormone–releasing mechanisms.

CJC-1295 is commonly researched for its extended activity profile within growth hormone pathways, while Ipamorelin is studied for its selective interaction with ghrelin receptors. Together, this blend has been examined in laboratory models focused on cellular signalling, recovery processes, and metabolic research.

Key Research Interest Areas:

• Growth hormone signalling pathways
  
• Cellular recovery & regeneration research
  
• Metabolic and body composition studies
  
• Muscle and tissue research models
  

Why This Blend Is Researched Together:

• Complementary peptide interaction
  
• Widely referenced in growth hormone pathway research
  
• Stable, well-studied peptide combination